These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27993849)

  • 1.
    Jones CL; Singh SS; Alamneh Y; Casella LG; Ernst RK; Lesho EP; Waterman PE; Zurawski DV
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Novel
    Gerson S; Betts JW; Lucaßen K; Nodari CS; Wille J; Josten M; Göttig S; Nowak J; Stefanik D; Roca I; Vila J; Cisneros JM; La Ragione RM; Seifert H; Higgins PG
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
    Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.
    López-Rojas R; McConnell MJ; Jiménez-Mejías ME; Domínguez-Herrera J; Fernández-Cuenca F; Pachón J
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4587-9. PubMed ID: 23836165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment.
    Park YJ; Hong DJ; Yoon EJ; Kim D; Choi MH; Hong JS; Lee H; Yong D; Jeong SH
    Ann Lab Med; 2018 Nov; 38(6):545-554. PubMed ID: 30027698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
    Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.
    López-Rojas R; Domínguez-Herrera J; McConnell MJ; Docobo-Peréz F; Smani Y; Fernández-Reyes M; Rivas L; Pachón J
    J Infect Dis; 2011 Feb; 203(4):545-8. PubMed ID: 21216865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.
    Choi HJ; Kil MC; Choi JY; Kim SJ; Park KS; Kim YJ; Ko KS
    Int J Antimicrob Agents; 2017 Jan; 49(1):102-106. PubMed ID: 27842758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.
    Pournaras S; Poulou A; Dafopoulou K; Chabane YN; Kristo I; Makris D; Hardouin J; Cosette P; Tsakris A; Dé E
    Antimicrob Agents Chemother; 2014; 58(2):828-32. PubMed ID: 24247145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.
    Arroyo LA; García-Curiel A; Pachón-Ibañez ME; Llanos AC; Ruiz M; Pachón J; Aznar J
    J Clin Microbiol; 2005 Feb; 43(2):903-5. PubMed ID: 15695701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France.
    Rolain JM; Roch A; Castanier M; Papazian L; Raoult D
    J Infect Dis; 2011 Oct; 204(7):1146-7. PubMed ID: 21881132
    [No Abstract]   [Full Text] [Related]  

  • 17. Whole-genome shotgun sequences of seven colistin-resistant Acinetobacter baumannii isolates from bacteraemia.
    Vijayakumar S; S BA; Kanthan K; Veeraraghavan B
    J Glob Antimicrob Resist; 2018 Mar; 12():155-156. PubMed ID: 29410025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
    Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.